Paranasal sinus cancer, though rare, presents significant challenges in both diagnosis and treatment. These cancers originate in the nasal cavity and sinuses, often diagnosed at an advanced stage due to their subtle symptoms like congestion or facial pain. Research in this area focuses on improving early detection methods, such as imaging techniques and biomarker identification, to enable timely interventions.
Furthermore, advancements in treatment modalities like surgery, radiation therapy, and chemotherapy aim to enhance outcomes and preserve quality of life for patients. Immunotherapy and targeted therapies also hold promise in addressing specific genetic mutations driving these cancers. Collaborative efforts between oncologists, surgeons, and researchers are vital in unraveling the complexities of paranasal sinus cancer and devising more effective strategies to combat it.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States